Combination of a farnesyl tranferase inhibitor with an antihormonal agent for the treatment of breast cancer

Details for Australian Patent Application No. 2004289256 (hide)

Owner Schering Corporation

Inventors Alland, Leila; Bishop, Walter Robert; Kirschmeier, Paul; Tendler, Craig; Long, Brian

Agent Griffith Hack

Pub. Number AU-A-2004289256

PCT Pub. Number WO2005/046691

Priority 60/517,820 06.11.03 US

Filing date 4 November 2004

Wipo publication date 26 May 2005

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4545 (2006.01)

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/5685 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/046691 Priority application(s): WO2005/046691

14 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289263-Ultrasonic surgical blade and instrument having a gain step

2004289252-Preparation and composition of Interalpha inhibitor proteins from human plasma for therapeutic use